Bacterial contamination in ascitic fluid is associated with the development of clinically relevant pancreatic fistula after pancreatoduodenectomy

Pancreas

Volumn 42, Issue 4, 2013, Pages 701-706

  Nagakawa, Yuichi ^a   Matsudo, Takaaki ^a   Hijikata, Yousuke ^a   Kikuchi, Satoru ^a   Bunso, Kyo ^a   Suzuki, Yoshiaki ^a   Kasuya, Kazuhiko ^a   Tsuchida, Akihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

abdominal infection; bacteria; pancreatic fistula; pancreatoduodenectomy; the International Study Group on Pancreatic Fistula

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTIAM; CEPHEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PENICILLIN DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCITES FLUID; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHOLANGITIS; DISEASE ASSOCIATION; DISEASE COURSE; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SURGICAL DRAINAGE;

ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; BACTERIAL INFECTIONS; CHOLANGITIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TIME FACTORS;

EID: 84876870603     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31826d3a41     Document Type: Article

References (20)

1. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006; 244: 10-15.
2. Buchler MW, Friess H, Wagner M, et al. Pancreatic fistula after pancreatic head resection. Br J Surg. 2000; 87: 883-889.
3. Munoz-Bongrand N, Sauvanet A, Denys A, et al. Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg. 2004; 199: 198-203.
4. Pessaux P, Msika S, Atalla D, et al. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: A multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg. 2003; 138: 314-324.
5. Grobmyer SR, Rivadeneira DE, Goodman CA, et al. Pancreatic anastomotic failure after pancreaticoduodenectomy. Am J Surg. 2000; 180: 117-120.
6. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000; 232: 419-429.
7. Bassi C, Falconi M, Molinari E, et al. Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: Results of a prospective randomized trial. Surgery. 2003; 134: 766-771.
8. D'Andrea AA, Costantino V, Sperti C, et al. Human fibrin sealant in pancreatic surgery: It is useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol. 1994; 26: 283-286.
9. Suc B, Msika S, Fingerhut A, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: Prospective randomized trial. Ann Surg. 2003; 237: 57-65.
10. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery. 2005; 138: 8-13.
11. Kawai M, Tani M, Terasawa H, et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: Prospective study for 104 consecutive patients. Ann Surg. 2006; 244: 1-7.
12. Bassi C, Molinari E, Malleo G, et al. Early versus late drain removal after standard pancreatic resections: Results of a prospective randomized trial. Ann Surg. 2010; 252: 207-214.
13. Miedema BW, Sarr MG, van Heerden JA, et al. Complications following pancreaticoduodenectomy. Current management. Arch Surg. 1992; 127: 945-950.
14. Kawai M, Kondo S, Yamaue H, et al. Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: Multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2011; 18: 601-608.
15. Cerise EJ, Pierce WA, Diamond DL. Abdominal drains: Their role as a source of infection following splenectomy. Ann Surg. 1970; 171: 764-769.
16. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: The role of biofilms. Prog Drug Res. 1991; 37: 91-105.
17. Costerton JW, Irvin RT, Cheng KJ. The bacterial glycocalyx in nature and disease. Annu Rev Microbiol. 1981; 35: 299-324.
18. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999; 20: 250-280.
19. Povoski SP, Karpeh MS Jr, Conlon KC, et al. Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg. 1999; 3: 496-505.
20. Kajiwara T, Sakamoto Y, Morofuji N, et al. An analysis of risk factors for pancreatic fistula after pancreaticoduodenectomy: Clinical impact of bile juice infection on day 1. Langenbecks Arch Surg. 2010; 395: 707-712.